US 12162948
Methods of engineering transferrin receptor binding polypeptides
granted A61KA61K38/00
Quick answer
US patent 12162948 (Methods of engineering transferrin receptor binding polypeptides) held by DENALI THERAPEUTICS INC. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00